M. Franco G. Salvoza

Array ( [id] => 6187876 [patent_doc_number] => 20110171253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'NOVEL ASTROVIRUS' [patent_app_type] => utility [patent_app_number] => 13/000477 [patent_app_country] => US [patent_app_date] => 2009-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6630 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171253.pdf [firstpage_image] =>[orig_patent_app_number] => 13000477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6622733 [patent_doc_number] => 20100003704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'IN SITU detection of early stages and late stages HPV infection' [patent_app_type] => utility [patent_app_number] => 12/456055 [patent_app_country] => US [patent_app_date] => 2009-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17397 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003704.pdf [firstpage_image] =>[orig_patent_app_number] => 12456055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6125567 [patent_doc_number] => 20110086063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'VACCINES FOR PREVENTION AND TREATMENT OF ADDICTION' [patent_app_type] => utility [patent_app_number] => 12/995851 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22221 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086063.pdf [firstpage_image] =>[orig_patent_app_number] => 12995851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11507323 [patent_doc_number] => 09598470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-21 [patent_title] => 'Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways' [patent_app_type] => utility [patent_app_number] => 12/467799 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 47 [patent_no_of_words] => 50856 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12467799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952501 [patent_doc_number] => 20110033499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'ANTI-VIRAL NUTRACEUTICAL' [patent_app_type] => utility [patent_app_number] => 12/988744 [patent_app_country] => US [patent_app_date] => 2009-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9464 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033499.pdf [firstpage_image] =>[orig_patent_app_number] => 12988744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10594789 [patent_doc_number] => 09315866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-19 [patent_title] => 'Combination of MAL and CADM1 markers for HPV induced invasive cancers and their high-grade precursor lesions' [patent_app_type] => utility [patent_app_number] => 12/937981 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7997 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11921567 [patent_doc_number] => 09789129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Stimulation of an immune response by enantiomers of cationic lipids' [patent_app_type] => utility [patent_app_number] => 12/988236 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 11392 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12988236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254927 [patent_doc_number] => 20100028995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Tetranectin Trimerizing Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/420680 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 23514 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028995.pdf [firstpage_image] =>[orig_patent_app_number] => 12420680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6188698 [patent_doc_number] => 20110171628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'CERVICAL SCREENING ALGORITHMS' [patent_app_type] => utility [patent_app_number] => 12/922131 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6631 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171628.pdf [firstpage_image] =>[orig_patent_app_number] => 12922131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6119150 [patent_doc_number] => 20110076671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'USE OF SYNTHETIC PEPTIDE DERIVED FROM ZEBRA PROTEIN FOR THE IN VITRO DIAGNOSIS OF THE EPSTEIN-BARR VIRUS (EBV) REACTIVATION' [patent_app_type] => utility [patent_app_number] => 12/921804 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7656 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076671.pdf [firstpage_image] =>[orig_patent_app_number] => 12921804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385170 [patent_doc_number] => 20090226414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'METHOD FOR DETECTING INFECTIOUS PARVOVIRUS IN PHARMACEUTICAL PREPARATIONS' [patent_app_type] => utility [patent_app_number] => 12/400145 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15280 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226414.pdf [firstpage_image] =>[orig_patent_app_number] => 12400145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545427 [patent_doc_number] => 20090155304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Modified Cyanovirin-N Polypeptide' [patent_app_type] => utility [patent_app_number] => 12/277193 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21857 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155304.pdf [firstpage_image] =>[orig_patent_app_number] => 12277193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15130107 [patent_doc_number] => 10478490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Herpes simplex virus combined subunit vaccines and methods of use thereof [patent_app_type] => utility [patent_app_number] => 12/270772 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 54 [patent_no_of_words] => 55295 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12270772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564064 [patent_doc_number] => 20090136917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Systems and methods for viral therapy' [patent_app_type] => utility [patent_app_number] => 12/288887 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59453 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136917.pdf [firstpage_image] =>[orig_patent_app_number] => 12288887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9602608 [patent_doc_number] => 20140199291 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2014-07-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)' [patent_app_type] => utility [patent_app_number] => 12/678011 [patent_app_country] => US [patent_app_date] => 2008-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29301 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9602608 [patent_doc_number] => 20140199291 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2014-07-17 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)' [patent_app_type] => utility [patent_app_number] => 12/678011 [patent_app_country] => US [patent_app_date] => 2008-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29301 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588196 [patent_doc_number] => 20100291545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'ANTIBODY HAVING INHIBITORY ACTIVITY ON INFECTION WITH HEPATITIS C VIRUS (HCV) AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/670383 [patent_app_country] => US [patent_app_date] => 2008-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23714 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291545.pdf [firstpage_image] =>[orig_patent_app_number] => 12670383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508039 [patent_doc_number] => 20090081246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'METHOD FOR ISOLATING HEPATITIS C VIRUS PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/112758 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18509 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081246.pdf [firstpage_image] =>[orig_patent_app_number] => 12112758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6323676 [patent_doc_number] => 20100196993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'PERSISTENTLY INFECTIVE SENDAI VIRUS VECTOR' [patent_app_type] => utility [patent_app_number] => 12/595497 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 19027 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196993.pdf [firstpage_image] =>[orig_patent_app_number] => 12595497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681771 [patent_doc_number] => 20080247997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'EXTERNAL ANIMAL LAYER SANITATION USING BACTERIOPHAGE' [patent_app_type] => utility [patent_app_number] => 12/039634 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3018 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20080247997.pdf [firstpage_image] =>[orig_patent_app_number] => 12039634 [rel_patent_id] =>[rel_patent_doc_number] =>)